News
Health Literacy in Europe
The need to educate consumers for a healthier society.
Overall knowledge about health needs to be increased in our populations. That’s the..
Janssen’s Hepatitis C Medicine Wins Belgian Galien Prize 2012
On April 17 Janssen has won its fifth Belgian Galien prize in recognition of its new Hepatitis C medicine, telaprevir. Each year a pharmaceutical company from each of the twelve participating countries is named to win the award. With a..
The Patient's Voice On Therapeutic Innovation
Launch Meeting of EUPATI.
How to help patients become true patients’ advocates and how to involve them in the implementation of patient-centred pharmaceutical research and development? These were some of the main questions addressed at the launch meeting of the European..
Memories Are Everything
The challenge of Alzheimer’s disease
“The 7 Summits Climb for Alzheimer’s” of Alan Arnette started in late 2010 when he embarked on a yearlong challenge to climb seven of the world’s highest summits. With this effort he has reached 30 million..
Young Lions Shape The Future Of Healthcare
On March 10, 2012, the members of the Young Lions (YL) Health Parliament - an initiative started by Janssen Germany - convened in the NRW Forum Duesseldorf for their first sitting. The parliament consists of roughly 80 young people with..
Janssen Joins Neglected Tropical Disease Fight
On Monday 30 January 2012, Paul Stoffels, M.D., Worldwide Chairman, Pharmaceuticals, Johnson & Johnson, met in London with the World Health Organization (WHO), 12 other pharmaceutical companies, the Bill & Melinda Gates Foundation, the U.S. and U.K. governments, the World..
The Future of Healthcare in Africa
New possibilities for a continent.
Today we present a new report, “The Future of Healthcare in Africa”, written by researchers from the Economist Intelligence Unit (EIU) and commissioned by Janssen. This new report focuses on five possible future scenarios for African..
Alex Gorsky to Succeed Bill Weldon as CEO of Johnson & Johnson
On 21 February Johnson & Johnson announced that its Board of Directors has named Alex Gorsky Chief Executive Officer (CEO) of Johnson & Johnson effective April 26, 2012, the date of the Company’s Annual Meeting of Shareholders. Mr. Gorsky was..
Our Commitment To People Living With HIV
Anyone familiar with our Company knows that our responsibility and commitment are always focused on the needs of patients.
This is more than a belief; it’s a way of life for my Global Access & Partnerships team. For people living with..